Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing
Reexamination Certificate
2007-10-30
2007-10-30
Jones, D. L. (Department: 1618)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
C424S001110, C424S001650, C424S009200, C424S009300, C424S009400, C424S009500, C424S009600
Reexamination Certificate
active
10323592
ABSTRACT:
The invention is based on the realisation that inflamed plaques in blood vessel walls, which are potentially vulnerable to rupture, can be detected at elevated temperatures which are lower than previously realised. In particular, the low temperatures at which inflamed plaque can be detected are often associated with systems in which blood flow is generally close to normal in particular temperature differences above zero but not more than 0.39° C. have been found to be indicative of the presence of inflamed plaque.
REFERENCES:
patent: 3589360 (1971-06-01), Sinclair
patent: 5237996 (1993-08-01), Waldman et al.
patent: 5345938 (1994-09-01), Nishiki et al.
patent: 5771895 (1998-06-01), Slager
patent: 5935075 (1999-08-01), Casscells et al.
patent: 5967984 (1999-10-01), Chu et al.
patent: 6053937 (2000-04-01), Edwards et al.
patent: 6245026 (2001-06-01), Campbell et al.
patent: 6763261 (2004-07-01), Casscells et al.
Nakano et al (J. Nippon Med. Sch., 2001, 68(6), 482-489).
WO/01/74263.
Diamantopoulos Leonidas
Van Langenhove Glenn
Bromberg & Sunstein LLP
Jones D. L.
NV Thermocore Medical Systems SA
LandOfFree
Determining vulnerable plaque in blood vessels does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Determining vulnerable plaque in blood vessels, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Determining vulnerable plaque in blood vessels will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3875620